A Randomized Phase II Study of Nivolumab and Temozolomide vs Temozolomide alone in newly diagnosed elderly patients with Glioblastoma (NUTMEG)
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
University of Sydney
Start Date
October 12, 2020
End Date
December 31, 2022
Administered By
Duke Cancer Institute
Awarded By
University of Sydney
Start Date
October 12, 2020
End Date
December 31, 2022